Hypnosis Mask: a New Approach to Management of Pain in Medical Imaging
NCT ID: NCT03711643
Last Updated: 2025-12-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
88 participants
INTERVENTIONAL
2019-05-07
2021-10-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Optimizing pain management
An experimental group receive a standard pain management and benefit the hypnotic mask (Hypnos pro).
Periprostatic nerve block
4 injections of 2 cc of lidocaine for a Periprostatic nerve block
hypnosis mask
The mask HYPNOS pro stimulates the imagination of the user by means of 6 diodes among 3 by eye.
Just before the introduction of ultrasound probe, the patient put the hypnotic mask and choose a session.Twenty minutes after the removal of the probe, an healthworker assess the painful patient with the visual analogue scale VAS, after this the patient fulfill the STATE- TRAIT Anxiety Inventory (STAI) form Y-A.
standard pain management
Periprostatic nerve block
4 injections of 2 cc of lidocaine for a Periprostatic nerve block
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Periprostatic nerve block
4 injections of 2 cc of lidocaine for a Periprostatic nerve block
hypnosis mask
The mask HYPNOS pro stimulates the imagination of the user by means of 6 diodes among 3 by eye.
Just before the introduction of ultrasound probe, the patient put the hypnotic mask and choose a session.Twenty minutes after the removal of the probe, an healthworker assess the painful patient with the visual analogue scale VAS, after this the patient fulfill the STATE- TRAIT Anxiety Inventory (STAI) form Y-A.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Having accepted and signed the consent, for performing a prostate biopsy ultrasound examination
* No contraindication to the gesture
* Supporting the left lateral decubitus
Exclusion Criteria
* Patient with hearing and / or epilepticus and / or dementia and / or having a history of stroke and / or allergic to lidocaine
* Person unable to consent, or benefiting from a system of legal protection (tutelage / curatorship).
* Patients with epileptic seizures.
* Patients with known allergies to plastics and other resins that may develop allergic contact dermatitis.
* Patients who are hypersensitive to radio frequency.
50 Years
75 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Lille
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Philippe Puech, MD,PhD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Lille
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital Claude Huriez, CHU
Lille, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-A01673-52
Identifier Type: OTHER
Identifier Source: secondary_id
2017_84
Identifier Type: -
Identifier Source: org_study_id